Placebo had little impact on reducing serum TNF-α concentration (p = 0.3700; Figure 4, left panel), but FCE significantly inhibited the TNF-α concentration (p = 0.0001; Figure 4, right panel) of patients with prediabetes during the intervention. This evidence concerns the gene TNF and prediabetes syndrome.